Glycogen storage disease type Ia in Argentina: two novel glucose-6-phosphatase mutations affecting protein stability
Introduction
Glucose-6-phosphatase (G6Pase, EC 3.1.3.9), which is a key enzyme in the homeostatic regulation of blood glucose, catalyses the hydrolysis of glucose-6-phosphate (G6P) to glucose and phosphate in the terminal step of gluconeogenesis and glycogenolysis. A deficiency in G6Pase causes glycogen storage disease type Ia (GSD-Ia, MIM #232200), an autosomal recessive disorder characterized by fasting hypoglycemia, hepatomegaly, short stature, hyperlactacidemia, hyperuricemia, and hyperlipidemia [1], [2].
The human glucose-6-phosphatase gene (G6PC, GDB 231927) [3] contains five exons spanning approximately 12.5 kb DNA located on chromosome 17q21. The encoded enzyme is anchored to the ER by nine transmembrane helices with the amino (N)-terminus in the lumen and the carboxyl (C)-terminus in the cytoplasm [4]. At present, 82 separate mutations have been identified in the G6PC gene of GSD-Ia patients (http://uwcmml1s.uwcm.ac.uk/uwcm/mg/search/231927.html). Structure and function studies of 48 missense and the p.Phe327del mutations grouped as active site, helical and non-helical have suggested that the structural integrity of transmembrane helices is critical for the stability and enzymatic activity of G6Pase [5]. In this study, we report the results of the first molecular analysis of the G6PC gene in eleven Argentinean patients and functional characterization of two novel mutations that abolish enzymatic activity and affect protein stability.
Section snippets
Patients
During the last 22 years, 11 GSD-I patients (6 females and 5 males) from 8 unrelated families were investigated. The diagnosis of GSD-I was based on typical clinical and laboratory findings; in 8 patients (six families) the G6Pase activity in liver biopsy samples was determined by different methods: in 4 patients the activity was measured in fresh liver homogenate according to Ricketts’ procedure [6] (period 1982–1988), in other 4 probands the enzymatic assay was performed in disrupted and
Results and discussion
Four missense and one deletion mutations have been identified in the G6PC gene of 10 Argentinean GSD-Ia patients (Table 2). The genotypes of the 10 patients were: [p.Gln54Pro] + [p.Gln54Pro] (3 patients, 2 families), [p.Fs35Ter] + [p.Fs35Ter] (2 unrelated patients), [p.Arg83Cys] + [p.Arg83Cys] (one patient), [p.Gln54Pro] + [p.Thr16Arg] (2 sisters), and [p.Arg83Cys] + [p.Tyr209Cys] (2 brothers).
In one patient, no mutation was detected in the G6PC coding region, therefore a complete analysis of the
Acknowledgments
C.J.A. was supported by a travel fellowship from the Universidad Católica de Córdoba. We thank Dra. A.M. Smania for her invaluable help and Dra. Laura E. Larovere for critical reading of the manuscript. This work was supported in part by the Agencia Córdoba Ciencia.
References (9)
- et al.
Transmembrane topology of glucose-6-phosphatase
J. Biol. Chem.
(1998) - et al.
The molecular basis of glycogen storage disease type Ia: structure and function analysis of mutations in glucose-6-phosphatase
J. Biol. Chem.
(2002) An improved micromethod for the determination of glucose-6-phosphatase activity
Clin. Chim. Acta
(1963)- et al.
A new microtechnique for the analysis of the human hepatic microsomal glucose-6-phosphatase system
Clin. Chim. Acta
(1988)
Cited by (12)
A novel homozygous no-stop mutation in G6PC gene from a Chinese patient with glycogen storage disease type Ia
2014, GeneCitation Excerpt :Genomic DNA was extracted from peripheral leukocytes using QIAamp® DNA Blood Mini Kit (Qiagen, Germany). Five exons of the G6PC gene (GenBank accession no. U01120) and flanking splicing-sites were amplified using polymerase chain reaction (PCR) with previously reported primers (Angaroni et al., 2004; Lei et al., 1993). Each PCR reaction was performed in a total volume of 50 μl containing 10 μl of GoTaq® 5 × Reaction Buffer, 0.25 μl of GoTaq® DNA Polymerase (Promega, USA), 1 μl of 10 mM dNTP Mix, 1 μl of 30 μM each forward and reverse primers, 4 μl of 25 ng/μl genomic DNA template, and 32.75 μl of nuclease-free water.
Glycogen storage disease type Ib without neutropenia generated by a novel splice-site mutation in the glucose-6-phosphate translocase gene
2006, Molecular Genetics and MetabolismNovel mutations of the g6pc gene in malaysians with glycogen storage disease 1a (gsd1a)
2021, Malaysian Journal of ScienceClinical, Biochemical and Molecular Characterization of a Cohort of Glycogen Storage Disease Type I Patients in a High Complexity Hospital in Argentina
2021, Journal of Inborn Errors of Metabolism and ScreeningClinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control
2017, Journal of Inherited Metabolic Disease